Prices delayed by at least 15 minutes | Print
Tissue Regenix Group PLC (TRX)
ORD 0.1POpen
29.00p
Previous close
29.00p
Trade high
29.80p
Volume
13,550
Year high
67.00p
Year low
25.00p
Dividend yield
–
Market capitalisation
£21.23 mn
P/E ratio
–
ISIN
GB00BNTXR104
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Itsproduct portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 22/08/2025 | 04:24:01 | 29.8 | 13,500 | 4,023.00 |
| 22/08/2025 | 11:33:07 | 28.75 | 50 | 14.38 |
| 21/08/2025 | 03:20:12 | 28.75 | 160 | 46.00 |
| 21/08/2025 | 12:31:31 | 28.75 | 1,061 | 305.04 |
| 20/08/2025 | 04:29:48 | 28.75 | 333 | 95.74 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.